Search company, investor...
CancerIQ company logo


Founded Year



Series B | Alive

Total Raised


Last Raised

$14M | 1 yr ago

About CancerIQ

CancerIQ operates a web-based big data application that converts oncology data stored in unstructured enterprise data warehouses into research-quality data for secondary use. It is a proven data management and data sharing tool for translational research and contains a unique data model that integrates genomics into clinical practice. The company was founded in 2013 and is based in Chicago, Illinois.

Headquarters Location

515 N. State Suite 1025

Chicago, Illinois, 60654,

United States


Missing: CancerIQ's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CancerIQ's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing CancerIQ

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CancerIQ is included in 4 Expert Collections, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Digital Health

12,673 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

2,337 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

Latest CancerIQ News

CancerIQ Raises $14M Series B Funding

May 2, 2022

CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, announced it closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), as well as CancerIQ's Series A lead investor, HealthX Ventures, also participated in the Series B round. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

CancerIQ Frequently Asked Questions (FAQ)

  • When was CancerIQ founded?

    CancerIQ was founded in 2013.

  • Where is CancerIQ's headquarters?

    CancerIQ's headquarters is located at 515 N. State, Chicago.

  • What is CancerIQ's latest funding round?

    CancerIQ's latest funding round is Series B.

  • How much did CancerIQ raise?

    CancerIQ raised a total of $20.52M.

  • Who are the investors of CancerIQ?

    Investors of CancerIQ include HealthX Ventures, Merck Global Health Innovation Fund, McKesson Ventures, OSF Ventures, Amgen Ventures and 3 more.

  • Who are CancerIQ's competitors?

    Competitors of CancerIQ include SOAP Health.

Compare CancerIQ to Competitors


Therapha provides a clinical decision support system for comprehensive musculoskeletal triage and differential diagnoses over an AI-enabled platform. The company serves healthcare facilities and providers. It was founded in 2019 and is based in New York, New York.

Health Note Logo
Health Note

Health Note operates as a digital pre-visit planning platform, It transforms the patient experience and automates clinical electronic health record (EHR) documentation for providers. Its conversational texting walks patients through intake paperwork before the visit, while capturing clinically-relevant information to streamline office visits from front desk to encounter. Health Note was founded in 2018 and is based in San Francisco, California.

Notable Logo

Notable is a AI platform that automates and structures every physician-patient interaction. It is a voice-driven app built for Apple Watch, which utilizes voice wake features that allow clinicians to complete an encounter. The smart assistant automatically structures conversations, dictations, orders, and recommends the appropriate billing codes.

SOAP Health Logo
SOAP Health

SOAP Health provides artificial intelligence (AI) powered healthcare software. Its product includes Perfect Medical Interviewer, a voice and image-based conversational AI-powered digital human clinically validated to collect actionable patient data. It was formerly known as GeneYes and changed its name to SOAP Health. The company was founded in 2019 and is based in Boca Raton, Florida.

Phreesia Logo

Phreesia gives healthcare organizations a suite of applications to manage the patient intake process. Its SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. The company was founded in 2005 and is based in Wilmington, Delaware.

Epion Health Logo
Epion Health

Epion Health is a provider of software as a service patient engagement platform at the point of care, beginning with the patient check-in process. The service fully integrates with electronic health records and practice management systems and serves healthcare facilities and it fully integrates with electronic medical records and practice management systems. The company was founded in 2011 and is based in Hoboken, New Jersey. In September 2022, Epion Health was acquired by Kyruus. the terms of the transaction were not disclosed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.